In view of the similarity of cataracts and neuropathy in galactosefed and diabetic rats, the present experiments were undertaken to determine whether consumption of galactose-enriched diets (10, 25, or 50% by weight) also increases collagen crosslinking and permeation of vessels by 125I-albumin analagous to that observed in diabetic rats. The observations in these experiments: (a) demonstrate that consumption of galactose-enriched diets for 3 wk selectively increases '25I-albumin permeation of the same vascular beds affected in diabetic rats and by diabetic vascular disease in humans (i.e., the aorta and vessels in the eye, kidney, sciatic nerve, and new tissue formed in the diabetic milieu); (b) demonstrate that the susceptibility of the vasculature to aldose reductase-linked injury (increased permeability) varies greatly in different tissues; (c) indicate that collagen solubility (crosslinking) changes in galactose-fed rats differ sharply from those in diabetic rats; and (d) provide new evidence that consumption of galactose-enriched diets induces a hypogonadal state in male rats.
Introduction
The development of cataracts and impaired motor nerve conduction velocity in animals fed galactose-enriched diets is well known (1) (2) (3) (4) . The similarity of these phenomena to those occurring in diabetic animals and their association, in both conditions, with the accumulation ofpolyols (galactitol and sorbitol in galactose-fed and diabetic animals respectively) has been interpreted as evidence supporting the hypothesis that increased metabolism of glucose by the polyol pathway is an important factor in the pathogenesis of diabetic cataracts and neuropathy (5) (6) (7) . Additional support for this hypothesis has been provided by evidence that five structurally different chemical inhibitors of aldose reductase, the enzyme that catalyzes formation of galactitol and sorbitol from galactose and glucose respectively, prevent and reverse cataracts and neuropathy induced by diabetes and galactose ingestion (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
The possibility that the polyol pathway might also play a role in diabetic vascular disease is suggested by reports demonstrating aldose reductase activity in vessels (retina [16] [17] [18] , aorta [14] [15] [16] [17] [18] [19] [20] , and glomeruli [21, 22] ) as well as evidence that galactose ingestion causes thickening of retinal capillary basement membranes (which is prevented by inhibitors of aldose reductase) in rats (23) (24) (25) and retinal capillary microaneurysms in dogs (26) . We have recently reported that diabetes-induced increased vascular permeability and polyol levels in new tissue formed in diabetic rats (27) are prevented by castration (27) and by an inhibitor of aldose reductase (29, 30) . Diabetes-induced increases in collagen crosslinking, which appear to be mediated by lysyl oxidase (31) , were prevented by castration (which did not affect plasma glucose levels) but were unaffected by the aldose reductase inhibitor.
The studies described in this paper were undertaken to: (a) investigate whether imbalances in polyol metabolism associated with galactose ingestion also increase vascular permeation by 1251-albumin and collagen crosslinking in new granulation tissue, comparable to that induced by diabetes; and (b) to assess effects ofgalactose ingestion on '251-albumin permeation in other tissues involved by diabetic vascular disease in humans.
Methods
Animals. Male Sprague-Dawley rats weighing 180-280 g were divided into four groups. Group I (controls) was fed ground rat chow mixed with equal parts by weight ofdextrin; group II was fed ground chow containing 10% (by weight) galactose; group III was fed 25% galactose; and group IV 50% galactose mixed with ground chow. The day before initiation of the diet, sterile preweighed polyester fabric was implanted subcutaneously over the dorsolateral aspect of the thigh, as described in previous publications (27, 31) , to induce angiogenesis and new granulation tissue formation. 3 wk later, '251-albumin permeation, collagen crosslinking, and levels ofpolyols and myo-inositol were assessed in the new granulation tissue. Albumin permeation also was assessed in several other tissues including eyes, aorta, brain, heart, skeletal muscle, kidney, skin, cecum, and sciatic nerve.
The effects of two structurally different aldose reductase inhibitors (1 1, 12) (sorbinil and tolrestat, generously provided by Pfizer, Inc., New York, NY, and Ayerst Laboratories, New York, NY, respectively) on galactose-induced albumin permeation were assessed by adding sufficient quantities of each inhibitor to ground rat chow to provide a daily intake of -0.1 mmol inhibitor/kg body weight per d.
Assessment ofvascularpermeability. The techniques for preparation of radiolabeled tracers and for assessment of '25I-albumin permeation of vessels and crosslinking of collagen have been published (31, 32) and will be described only briefly. Assessment of vascular permeation by albumin is based on quantification of 1251I-albumin, 51Cr-red blood cell (RBC)', and 57Co-EDTA in blood and tissues sampled 6.5-8 min after intravenous injection of the tracers (32) in rats anesthetized with intraperitoneal Nembutal (35 mg/kg) or Inactin (-60 mg/kg). Because galactose-fed rats (and diabetic rats) tend to be more sensitive to anesthetic agents, as reflected in lower blood pressures, the dose of anesthetic was reduced by -25% in galactose-fed rats. The index ofalbumin permeation used in these studies, the tissue-to-blood-isotope ratio (TBIR-I/Cr) is derived from the formula: TBIR-I/Cr = ('25I-BSA/51Cr-RBC) for tissue/ (125I-BSA/5'Cr-RBC) for blood, where BSA is bovine serum albumin. A TBIR-I/Cr > 1 indicates that the volume of distribution of albumin relative to that of red cells is greater in the tissue than in large vessels and is indicative of permeation of the vasculature by albumin into the extravascular space. Because the capillary hematocrit is somewhat lower than that of large vessels (discussed in reference 32), the TBIR-I/Cr is always slightly> 1.
While the terms increased vascular permeability and increased vascular permeation by albumin are sometimes used interchangeably, it should be understood that these two terms are not synonymous. Permeability refers to the porosity (i.e., pore size, number, and surface area) ofthe vessel wall, whereas permeation refers to the movement ofa tracer molecule, i.e., '251-albumin, across the vessel wall. While an increase in the number and/or size of vascular pores large enough to accommodate albumin will be manifested by an increase in albumin permeation, an increase in albumin permeation also may occur as a consequence of hemodynamic changes leading to an increase in pressure gradients across vessel walls. Such changes would increase the filtration (permeation) of plasma water and proteins (including albumin) through existing pores without any change in porosity of the vessel wall. At the present time we do not know the mechanism(s) responsible for the diabetes-induced increase in albumin permeation of vessels in this model.
The TBIR for the "Co-EDTA/51Cr-RBC (TBIR-Co/Cr) also was determined. Because 57Co-EDTA is a much smaller molecule than 1251_ albumin, it permeates vessel walls much more readily and accesses virtually the entire extracellular space. If only the TBIR-I/Cr is determined and it is low or close to 1, it is not possible to know whether the low value is because ofthe permeability characteristics ofthe vessel or because the interstitial fluid space is so small that it is limiting, or because blood flow was so low that little albumin was available to access the interstitial fluid space. On the other hand, a low TBIR-I/Cr in the face of a high TBIR-Co/Cr indicates that the permeability characteristics of the vessel wall limited permeation of the vessel by '25I-albumin.
Assessment ofcollagen crosslinking and nonenzymatic glycosylation ofgranulation tissue. Because solubility ofcollagen in neutral salt solutions and dilute acids is inversely related to the extent of intermolecular crosslinks (33), we have quantified collagen solubility in 0.5 M acetic acid as an index of collagen crosslinking (31) . The implant tissue is first finely minced with scissors and a razor blade, and extracted with 0.15 M NaCl in 50 mM Tris (at neutral pH) at 4VC for 4-6 h to wash out plasma proteins and other soluble noncollagenous proteins. The minced tissue is then centrifuged and the residue is extracted at 4VC in 0.5 M acetic acid (1 ml/100 mg wet weight ofimplant) for 48 h with constant shaking.
After centrifugation at 37,000 g for 60 min, the supernatant and pellet are lyophylized and then hydrolyzed in 0.3 N oxalic acid for 2 h at 1000C. The samples are then cooled to room temperature and proteins are precipitated by addition of TCA. Hexoses bound nonenzymatically to proteins in the supernatants are measured as 5-hydroxymethylfurural by the thiobarbituric acid method (34) . The TCA precipitates are lyophylized and hydrolyzed in 6 N HCl for 24 h at 100IC for determination of hydroxyproline (35) and total protein (36) . Soluble and insoluble collagen are estimated from the hydroxyproline content of the supernatant and pellet, respectively, using a correction factor of 10 (based on evidence that hydroxyproline accounts for -10% ofthe weight oftype I collagen) (37) . Total collagen is considered equal to the sum of the soluble and insoluble fractions.
Measurement oftissue levels ofpolyols and myo-inositol. Chemical ionization gas chromatography-mass spectrometry (GC/MS) using ammonia as reagent gas and helium as carrier was used to measure tissue levels of the trimethylsilyl (TMS) derivatives of these substances (38) . Because TMS sorbitol does not separate from TMS galactitol or TMS mannitol, ifeither ofthese latter polyols are present they will be included in the values reported as sorbitol. In control rats, tissue levels of polyols are presumed to consist primarily of sorbitol, whereas in galactose-fed rats they would reflect primarily galactitol. Other analyses. Plasma glucose levels and galactose levels were determined by the glucose oxidase and galactose oxidase methods (39, 40) . Testosterone was extracted from plasma using benzene/petroleum ether (2:5) and was assayed by radioimmunoassay as described elsewhere (41) using a highly specific testosterone antiserum supplied by P. N. Rao (Southwest Foundation for Research and Education, San Antonio, TX).
Differences between groups were assessed by t test on arithmetic means and standard deviations unless otherwise indicated.
Results
Consumption of 10, 25, and 50% galactose-enriched diets for 3 wk caused corresponding marked incremental increases in 125I-albumin permeation of the vasculature in the eye and in new granulation tissue vessels (Table I ) and a somewhat smaller, but statistically significant increase in 1251-albumin permeation in the aorta. 1251I-albumin permeation also was markedly increased in the kidney and in sciatic nerve of (Inactin-anesthetized) rats fed 50% galactose diets (Table I) .
Data from an independent experiment performed to assess effects of aldose reductase inhibitors on 1251I-albumin permeation in rats fed a 50% galactose diet are shown in Table II Plasma glucose levels at the time of sacrifice (Table V) were increased 18% in rats fed 25% galactose (t = 2.32, P < 0.05) but did not differ from controls in rats fed 10 and 50% galactose diets. Plasma galactose levels were increased -2.5 times in rats fed 10% galactose (t = 3.03, P < 0.01), -11.5 times in those fed 25%, and -8 times in those fed 50% galactose diets (t = 24.35, P < 0.001, and t = 6.94, P < 0.001, respectively). Body weight gains were not significantly affected in rats fed 10 and 25% diets (Table V) , however, rats fed 50% galactose gained significantly less weight than controls (t = 2.64, P < 0.025) and rats fed 25% galactose (t = 2.99, P < 0.01). Prostate weights, expressed as a percentage of final body weight, were decreased by 17% in rats fed 25 and 50% galactose diets (t = 5.26, P< 0.001 vs. controls) ( Table V) . Plasma testosterone levels in rats fed 50% galactose diets were markedly reduced (t = 3.49, P < 0.005) (Table V) .
Granulation tissue levels of polyols were increased dramatically in rats fed 50% galactose to levels -135 times those observed in controls (t = 10.95, P < 0.001) (Table VI) . myo-Inositol levels, on the other hand, were virtually identical in galactosefed and control rats. Both inhibitors ofaldose reductase markedly reduced, but did not completely normalize, tissue polyol levels (Table VI) .
Discussion
The finding that galactose ingestion resulted in increased 125I-albumin permeation of the aorta and of vessels in the eyes, kidney, sciatic nerve, and new granulation tissue, but not in skin, skeletal muscle, brain, testes, and heart indicates that the vasculature in different tissues varies greatly in its susceptibility to polyol-linked injury. The finding that two structurally different inhibitors of aldose reductase largely prevented these galactoseinduced increases in vascular permeability indicates that galactose-induced vascular injury is linked to vascular aldose reductase activity. Further studies are needed to determine whether tissue (18) .
The increased albumin permeation in the aorta, eyes, and kidney in these galactose-fed rats contrasts sharply with the absence of such changes previously re'orted in diabetic rats (27) . More recent studies indicate that this apparent difference in al- (46) . On the other hand, Malmgren et al. (47) reported that the water content was increased but permeation by horseradish peroxidase was not increased in the sciatic nerve of galactose-fed Wistar rats; similarly, Jacobsen et al. (48) reported that the water content was increased although albumin permeation (Evans' blue technique) was not increased in the sciatic nerve of streptozotocindiabetic Wistar rats. The discordance in respect to the demonstration of increased vascular permeability in these different reports may be accounted for by methodological differences in the techniques used to assess vascular permeability as well as by differences in the age and strain of rats used. Mitchell (49) has reported that the Wistar strain of rats is particularly resistent to the development of galactose-induced cataracts and that in more susceptible strains of rats the rate of development and total incidence of cataracts are much higher in young rats than in older ones.
Thus, the vascular beds in which 125I-albumin permeation is increased by galactose ingestion do in fact correspond to those affected in diabetic rats and to vessels affected by complications in human diabetics. This finding supports the hypothesis that imbalances in sorbitol/inositol metabolism play an important role in mediating diabetes-induced vascular injury. This interpretation is further supported by evidence that galactose ingestion also causes: (a) retinal capillary basement membrane thickening in rats (indistinguishable from that observed in diabetic rats and humans), which is prevented by inhibitors of aldose reductase (23) (24) (25) , and (b) retinal capillary microaneurysms in dogs (26) . Additional studies are required to determine whether there is any causal relationship between increased permeation of the vasculature by macromolecules (i.e., 125I-albumin) and capillary basement membrane thickening or whether these two phenomena are independent manifestations of galactose effects on the vasculature. It is noteworthy, however, that the vascular permeability changes are evident within 3 wk in diabetic (27) and in galactose-fed rats, whereas the capillary basement membrane thickening in galactose-fed rats (23) (24) (25) and retinal microaneurysms in dogs (26) , required many months to several years, respectively, to develop.
It is unclear why new granulation tissue vessels formed in the diabetic or galactosemic milieu should be more readily permeated by 1251-albumin than neighboring connective tissue vessels (from which the new vessels must be derived) present in overlying skin and/or muscle before the onset of diabetes (27) or galactose ingestion. Nevertheless, this finding is consistent with well documented observations that new vessels formed by neovascularization of the retina in human diabetics are permeated by fluorescein to a much greater extent than neighboring retinal vessels whose origin antedates the onset of diabetes (50, 51) . While these observations (in rats and humans) could be accounted for by differences in maturation of these new vs. the older vessels, this would seem to be an unlikely explanation since the magnitude of the differences is not diminished after 6 mo of galactose ingestion or diabetes of comparable duration (unpublished observations). Alternatively, angiogenesis in the galactosemic or diabetic milieu may result in formation ofvessels whose intrinsic functional integrity is compromised or in vessels that are more susceptible to injury linked to increased flux of hexoses via the polyol pathway. The finding that granulation tissue polyol (presumably galactitol) levels were increased -135 fold in these galactose-fed rats whereas the polyol (presumably sorbitol) content of granulation tissue of diabetic rats is increased by only about two- 'Significantly different from controls at P < 0.001.
** Significantly different from controls and from rats fed 50% galactose at P < 0.001.
fold (28, 29) is consistent with evidence that the Km of aldose reductase for D-glucose is three times that of D-galactose (52) and that galactitol is oxidized by sorbitol dehydrogenase at only -3% ofthe rate for sorbitol (53) . That '251I-albumin permeation was no greater in granulation tissue of galactose-fed rats than in diabetic rats, despite the very large difference in tissue polyol levels, is consistent with the hypothesis that metabolic imbalances (i.e., in the redox state of pyridine nucleotides and glutathione) resulting from increased flux ofglucose through the polyol pathway, rather than absolute tissue polyol levels, mediate the functional and structural perturbations associated with increased polyol metabolism in various tissues. Other evidence in support ofthis hypothesis is the finding ofGreene et al. that myo-inositol supplementation of the diet of diabetic rats normalizes myoinositol levels, Na/K-ATPase activity, and motor nerve conduction velocity without affecting sorbitol levels (7). Several groups of investigators has postulated that imbalances in the redox state of pyridine nucleotides and glutathione may play an important role in cataract formation (54) (55) (56) . On the other hand, Kinoshita (57) has proposed that intracellular edema produced by osmotic effects ofintracellular polyol accumulation plays a critical role in the development of biochemical and metabolic changes involved in the pathogenesis of cataract formation in diabetic rats and in rats fed galactoseenriched diets. It is of interest in this regard that no evidence of endothelial swelling or edema is discernable in electron micrographs of granulation tissue vessels of galactose-fed rats or diabetic rats (unpublished data).
The finding that myo-inositol levels in granulation tissue of galactose-fed rats did not differ significantly from those of controls (Table VI) differs from our observations in diabetic rats in which myo-inositol levels are (significantly) decreased by 17-25% (28, 29) and from reports by other investigators in which myo-inositol levels are generally reduced by 20-40% in nerve and lens of diabetic (7, 12, 13, 15, 58, 59 ) and galactose-fed (4, 13, 58, 59) rats. This finding is of particular interest in view of evidence suggesting that reduced myo-inositol levels play a critical role in mediating diabetes-and galactose-induced nerve damage (7, 57) . On the other hand, the role of decreased myoinositol levels in the pathogenesis of diabetes-and galactoseinduced cataracts appears to be less well understood.
Previous investigators have demonstrated aldose reductase activity in the aorta and have reported that polyol production in the intact aorta and the activity of the enzyme isolated from aorta, brain, and skeletal muscle are modulated in vitro by a number of hormones and metabolites (19, 20) . There have been no reports, however, linking increased in vivo metabolism of hexoses by the polyol pathway to impaired functional integrity of the aorta, i.e., increased vascular permeability, under pathophysiological conditions. This new observation in galactose-fed rats is consistent with recent observations in diabetic rats mentioned earlier (43) and raises the possibility that acceleration of atherosclerotic vascular disease in human diabetics may reflect arterial injury (resulting in increased permeation of endothelium by atherogenic lipoproteins) mediated by increased metabolism of glucose via the polyol pathway.
The finding that collagen solubility was increased in new granulation tissue ofgalactose-fed rats sharply contrasts with the marked decrease observed in diabetic rats (28, 29, 31) . On the other hand, net collagen accumulation is not affected by galactose ingestion or by diabetes (28, 29, 31 ). An explanation for the divergent effects of diabetes and galactose feeding on collagen solubility is not readily apparent from these experiments on galactose-fed rats. The demonstration of prostatic atrophy in rats fed 25 and 50% galactose diets and the marked decrease in plasma testosterone levels in rats fed 50% galactose diets indicates that galactose-fed rats are, like diabetic rats, hypogonadal (61) (62) (63) . The finding that collagen solubility is increased in (intact hypogonadal) galactose-fed rats is consistent with the finding that castration of nondiabetic rats results in increased collagen solubility (28). On the other hand, the finding that collagen solubility is decreased in (intact hypogonadal) diabetic rats suggests that some additional factor peculiar to the diabetic milieu, possibility insulinopenia, counteracts the hypogonadal state in the diabetic rat and leads to increased lysyl oxidase-mediated collagen crosslinking (28).
In light of observations in diabetic and nondiabetic rats, we can virtually exclude the possibility that the decreased collagen solubility in these galactose-fed rats is linked to the small (albeit statistically significant) increase in hexoses bound in ketoamine linkage to granulation tissue proteins. In diabetic rats, nonenzymatic glycosylation of granulation tissue protein is increased by 50% (vs. 10%o in the galactose-fed rats) while collagen solubility is decreased (28); castration of diabetic rats has no effect on nonenzymatic glycosylation but completely prevents the diabetes-induced decrease in collagen solubility (28).
In summary, these findings: (a) demonstrate that consumption of galactose-enriched diets causes increased 125I-albumin permeation ofthe aorta and of vqssels in the eye, kidney, sciatic nerve, and new granulation tissue analagous to that observed in diabetic rats; (b) provide further evidence that imbalances in polyol/inositol metabolism are associated with increased vascular permeability independent of changes in collagen crosslinking (which is increased in the diabetic and decreased in galactosefed rats); and (c) provide new evidence that consumption of galactose-enriched diets induces a hypogonadal state in male rats.
